Analyst picks & changes

ICOS Corp. (ICOS)

Ragen MacKenzie analyst Andrew Heyward upgraded ICOS from "hold" to "accumulate," with a preferred buying range of below $6.25. He said he believes that the stock will rise in the short term as products make their way through development, and in the longer term based on ICOS's management, strong patent position in cell trafficking and partnership with Glaxo. ...